Polyclonal Antibody to Prostaglandin Endoperoxide Synthase 2 (PTGS2)
Code | Size | Price |
---|
PAA699Hu01-20ul | 20ul | £81.00 |
Quantity:
PAA699Hu01-100ul | 100ul | £149.00 |
Quantity:
PAA699Hu01-200ul | 200ul | £200.00 |
Quantity:
PAA699Hu01-1ml | 1ml | £454.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunocytochemistry (ICC)
- Immunohistochemistry- Frozen Section (IHC-F)
- Immunohistochemistry- Paraffin Embedded (IHC-P)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
PGG/HS; PGHS2; PHS2; HCox2; PTGS2; Prostaglandin Endoperoxide Synthase 2; Prostaglandin G/H Synthase And Cyclooxygenase; Prostaglandin H2 synthase 2
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.01% Proclin-300, 50% glycerol.
Item Name:
Cyclooxygenase-2
Reactivity:
Mu;
Source:
Polyclonal antibody preparation
Usage:
Western blotting: 0.01-5ug/mL<br/>Immunohistochemistry: 5-20ug/mL<br/>Optimal working dilutions must be determined by end user.
References
https://pubmed.ncbi.nlm.nih.gov/35398498/; https://sciencedirect.53yu.com/science/article/pii/S092666902300328X;
Related Products
Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recombinant Prostaglandin Endoperoxide Synthase 2 (PTGS2) | RPA699Hu01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||